Glycochenodeoxycholic acid

• CAT Number: I013686
• CAS Number: 640-79-9
• Molecular Formula: C₂₆H₄₃NO₅
• Molecular Weight: 449.62
• Purity: ≥95%
• Target: Apoptosis
• Solubility: DMSO: ≥ 29 mg/mL
• IUPAC Name: 2-[[(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid
• InChI: InChI=1S/C26H43NO5/c1-15(4-7-22(30)27-14-23(31)32)18-5-6-19-24-20(9-11-26(18,19)3)25(2)10-8-17(28)12-16(25)13-21(24)29/h15-21,24,28-29H,4-14H2,1-3H3,(H,27,30)(H,31,32)/t15-,16+,17-,18-,19+,20+,21-,24+,25+,26-/m1/s1
• InChIKey: GHCZAUBVMUEKKP-GYPHWSFCSA-N
• SMILES: CC(CCC(=O)NCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C

Glycochenodeoxycholic acid (Cat.No:I013686) is a bile acid conjugate formed by the binding of glycine to chenodeoxycholic acid. It plays a crucial role in the digestion and absorption of dietary fats by facilitating the emulsification of lipids in the intestines. GCDCA also functions as a signaling molecule, influencing various metabolic pathways, including cholesterol homeostasis and liver function. This compound is used in studies investigating bile acid metabolism, liver diseases, and drug development targeting gastrointestinal and hepatic disorders.